Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    February 2017
  1. NOBEN M, Verstockt B, de Bruyn M, Hendriks N, et al
    Epithelial organoid cultures from patients with ulcerative colitis and Crohn's disease: a truly long-term model to study the molecular basis for inflammatory bowel disease?
    Gut. 2017 Feb 3. pii: gutjnl-2016-313667. doi: 10.1136/gutjnl-2016-313667.
    PubMed     Text format    


    November 2016
  2. OLIVERA P, Danese S, Peyrin-Biroulet L
    Next generation of small molecules in inflammatory bowel disease.
    Gut. 2016 Nov 17. pii: gutjnl-2016-312912. doi: 10.1136/gutjnl-2016-312912.
    PubMed     Text format    


  3. DOTTI I, Mora-Buch R, Ferrer-Picon E, Planell N, et al
    Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis.
    Gut. 2016 Nov 1. pii: gutjnl-2016-312609. doi: 10.1136/gutjnl-2016-312609.
    PubMed     Text format     Abstract available


    October 2016
  4. IMHANN F, Vich Vila A, Bonder MJ, Fu J, et al
    Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Gut. 2016 Oct 8. pii: gutjnl-2016-312135. doi: 10.1136/gutjnl-2016-312135.
    PubMed     Text format     Abstract available


    September 2016
  5. HASLER R, Sheibani-Tezerji R, Sinha A, Barann M, et al
    Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease.
    Gut. 2016 Sep 30. pii: gutjnl-2016-311651. doi: 10.1136/gutjnl-2016-311651.
    PubMed     Text format     Abstract available


    May 2016
  6. STARR AE, Deeke SA, Ning Z, Chiang CK, et al
    Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC.
    Gut. 2016 May 23. pii: gutjnl-2015-310705. doi: 10.1136/gutjnl-2015-310705.
    PubMed     Text format     Abstract available


  7. SABINO J, Vieira-Silva S, Machiels K, Joossens M, et al
    Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Gut. 2016 May 20. pii: gutjnl-2015-311004. doi: 10.1136/gutjnl-2015-311004.
    PubMed     Text format     Abstract available


  8. QUEVRAIN E, Maubert MA, Sokol H, Devreese B, et al
    The presence of the anti-inflammatory protein MAM, from Faecalibacterium prausnitzii, in the intestinal ecosystem.
    Gut. 2016;65:882.
    PubMed     Text format    


  9. HONG SN, Park C, Park SJ, Lee CK, et al
    Deep resequencing of 131 Crohn's disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants.
    Gut. 2016;65:788-96.
    PubMed     Text format     Abstract available


    April 2016
  10. CANAVAN JB, Scotta C, Vossenkamper A, Goldberg R, et al
    Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
    Gut. 2016;65:584-94.
    PubMed     Text format     Abstract available


    March 2016
  11. ADAMI HO, Bretthauer M, Emilsson L, Hernan MA, et al
    The continuing uncertainty about cancer risk in inflammatory bowel disease.
    Gut. 2016 Mar 23. pii: gutjnl-2015-311003. doi: 10.1136/gutjnl-2015-311003.
    PubMed     Text format    


  12. TURSI A, Principi M, Picchio M, Giorgio F, et al
    Persistence of endoscopic rectal inflammation in UC treated with infliximab is not linked to ineffective TNFalpha downregulation.
    Gut. 2016;65:539-40.
    PubMed     Text format    


  13. HORNEF MW, Pabst O
    Real friends: Faecalibacterium prausnitzii supports mucosal immune homeostasis.
    Gut. 2016;65:365-7.
    PubMed     Text format    


  14. QUEVRAIN E, Maubert MA, Michon C, Chain F, et al
    Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
    Gut. 2016;65:415-25.
    PubMed     Text format     Abstract available


  15. BRYANT RV, Burger DC, Delo J, Walsh AJ, et al
    Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
    Gut. 2016;65:408-14.
    PubMed     Text format     Abstract available


    February 2016
  16. NORGARD BM, Larsen PV, Fedder J, de Silva PS, et al
    Live birth and adverse birth outcomes in women with ulcerative colitis and Crohn's disease receiving assisted reproduction: a 20-year nationwide cohort study.
    Gut. 2016 Feb 26. pii: gutjnl-2015-311246. doi: 10.1136/gutjnl-2015-311246.
    PubMed     Text format     Abstract available


  17. COLOMBEL JF, Sands BE, Rutgeerts P, Sandborn W, et al
    The safety of vedolizumab for ulcerative colitis and Crohn's disease.
    Gut. 2016 Feb 18. pii: gutjnl-2015-311079. doi: 10.1136/gutjnl-2015-311079.
    PubMed     Text format     Abstract available


  18. KUMMEN M, Holm K, Anmarkrud JA, Nygard S, et al
    The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Gut. 2016 Feb 17. pii: gutjnl-2015-310500. doi: 10.1136/gutjnl-2015-310500.
    PubMed     Text format     Abstract available


  19. MARCHESI JR, Adams DH, Fava F, Hermes GD, et al
    The gut microbiota and host health: a new clinical frontier.
    Gut. 2016;65:330-9.
    PubMed     Text format     Abstract available


  20. CHAMAILLARD M, Radulovic K
    Defining dysbiosis threatens Koch's postulates and current dogma on the role of Paneth cells in Crohn's disease.
    Gut. 2016;65:190-1.
    PubMed     Text format    


  21. SCHAUBECK M, Clavel T, Calasan J, Lagkouvardos I, et al
    Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence.
    Gut. 2016;65:225-37.
    PubMed     Text format     Abstract available


  22. REHMAN A, Rausch P, Wang J, Skieceviciene J, et al
    Geographical patterns of the standing and active human gut microbiome in health and IBD.
    Gut. 2016;65:238-48.
    PubMed     Text format     Abstract available


    December 2015
  23. GOWER-ROUSSEAU C, Sarter H, Savoye G, Tavernier N, et al
    Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort.
    Gut. 2015 Dec 8. pii: gutjnl-2015-310151. doi: 10.1136/gutjnl-2015-310151.
    PubMed     Text format     Abstract available


  24. TURNER D, Doveh E, Cohen A, Wilson ML, et al
    Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
    Gut. 2015;64:1898-904.
    PubMed     Text format     Abstract available


  25. ZEISSIG S, Petersen BS, Tomczak M, Melum E, et al
    Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.
    Gut. 2015;64:1889-97.
    PubMed     Text format     Abstract available


    November 2015
  26. MOSLI MH, Feagan BG, Zou G, Sandborn WJ, et al
    Reproducibility of histological assessments of disease activity in UC.
    Gut. 2015;64:1765-73.
    PubMed     Text format     Abstract available


  27. WU W, He C, Liu C, Cao AT, et al
    miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD.
    Gut. 2015;64:1755-64.
    PubMed     Text format     Abstract available


    October 2015
  28. VANDE CASTEELE N, Khanna R, Levesque BG, Stitt L, et al
    The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease.
    Gut. 2015;64:1539-45.
    PubMed     Text format     Abstract available


  29. SADAGHIAN SADABAD M, Regeling A, de Goffau MC, Blokzijl T, et al
    The ATG16L1-T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn's disease patients.
    Gut. 2015;64:1546-52.
    PubMed     Text format     Abstract available


    September 2015
  30. DANESE S, Peyrin-Biroulet L, Fiorino G
    Predicting future disease course in Crohn's disease by colonoscopy or magnetic resonance: which is the crystal ball?
    Gut. 2015;64:1347-8.
    PubMed     Text format    


  31. BOETTLER T, Lutz L, Schmidt N, Thimme R, et al
    An uncommon presentation of a common pathogen.
    Gut. 2015;64:1411.
    PubMed     Text format    


  32. JAUREGUI-AMEZAGA A, Rimola J, Ordas I, Rodriguez S, et al
    Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics.
    Gut. 2015;64:1397-402.
    PubMed     Text format     Abstract available


  33. BRESSENOT A, Salleron J, Bastien C, Danese S, et al
    Comparing histological activity indexes in UC.
    Gut. 2015;64:1412-8.
    PubMed     Text format     Abstract available


  34. BERNSTEIN CN, Nugent Z, Targownik LE, Singh H, et al
    Predictors and risks for death in a population-based study of persons with IBD in Manitoba.
    Gut. 2015;64:1403-11.
    PubMed     Text format     Abstract available


    August 2015
  35. BOSCHETTI G, Assaad S, Balme B, Boyer S, et al
    A challenging case of multiple splenic and pancreatic lesions in a patient with Crohn's disease.
    Gut. 2015 Aug 5. pii: gutjnl-2015-310130. doi: 10.1136/gutjnl-2015-310130.
    PubMed     Text format    


  36. BILLIET T, Vande Casteele N, Van Stappen T, Princen F, et al
    Immunogenicity to infliximab is associated with HLA-DRB1.
    Gut. 2015;64:1344-5.
    PubMed     Text format    


  37. STEENHOLDT C, Ainsworth MA
    Authors' response: Importance of defining loss of response before therapeutic drug monitoring.
    Gut. 2015;64:1340-1.
    PubMed     Text format    


  38. D'HAENS G, Sandborn WJ, Colombel JF, Rutgeerts P, et al
    A phase II study of laquinimod in Crohn's disease.
    Gut. 2015;64:1227-35.
    PubMed     Text format     Abstract available


    July 2015
  39. CIUCCI T, Ibanez L, Boucoiran A, Birgy-Barelli E, et al
    Bone marrow Th17 TNFalpha cells induce osteoclast differentiation, and link bone destruction to IBD.
    Gut. 2015;64:1072-81.
    PubMed     Text format     Abstract available


  40. SYRBE U, Siegmund B
    Bone marrow Th17 TNFalpha cells induce osteoclast differentiation and link bone destruction to IBD.
    Gut. 2015;64:1011-2.
    PubMed     Text format    


  41. LAKATOS PL, Burisch J
    Environment and invironment in IBDs: partners in crime.
    Gut. 2015;64:1009-10.
    PubMed     Text format    


    June 2015
  42. HART PA, Levy MJ, Smyrk TC, Takahashi N, et al
    Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis (type 2 autoimmune pancreatitis): the Mayo Clinic experience.
    Gut. 2015 Jun 17. pii: gutjnl-2015-309275. doi: 10.1136/gutjnl-2015-309275.
    PubMed     Text format     Abstract available


  43. REINISCH W, Panes J, Khurana S, Toth G, et al
    Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study.
    Gut. 2015;64:894-900.
    PubMed     Text format     Abstract available


  44. BOUGUEN G, Langlois A, Djouina M, Branche J, et al
    Intestinal steroidogenesis controls PPARgamma expression in the colon and is impaired during ulcerative colitis.
    Gut. 2015;64:901-10.
    PubMed     Text format     Abstract available


    May 2015
  45. KHALILI H, Chan AT
    Author response: oral contraceptives and Crohn's disease.
    Gut. 2015;64:854.
    PubMed     Text format    


  46. FU SH, Lin MH, Yeh LT, Wang YL, et al
    Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response.
    Gut. 2015;64:765-75.
    PubMed     Text format     Abstract available


  47. NALLEWEG N, Chiriac MT, Podstawa E, Lehmann C, et al
    IL-9 and its receptor are predominantly involved in the pathogenesis of UC.
    Gut. 2015;64:743-55.
    PubMed     Text format     Abstract available


    April 2015
  48. YANG SK, Ye BD, Song K
    ATG16L1 contributes to Crohn's disease susceptibility in Koreans: overmuch concern for ethnic difference?
    Gut. 2015;64:687-8.
    PubMed     Text format    


  49. JAMES SL, Christophersen CT, Bird AR, Conlon MA, et al
    Abnormal fibre usage in UC in remission.
    Gut. 2015;64:562-70.
    PubMed     Text format     Abstract available


  50. GENUA M, D'Alessio S, Cibella J, Gandelli A, et al
    The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation.
    Gut. 2015;64:589-600.
    PubMed     Text format     Abstract available


    December 2014
  51. JOOSSE ME, Schipper ME, Libbrecht L, Buuren HR, et al
    Recurrent cholangitis in a 65-year-old man.
    Gut. 2014 Dec 22. pii: gutjnl-2014-308726. doi: 10.1136/gutjnl-2014-308726.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: